About Keith Hoffman
Form D filings for Proteas Bioanalytics in 2021 list Keith Hoffman as director.
Keith Hoffman first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Keith Hoffman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Keith Hoffman works with at each company, as listed on that company's latest Form D.
Proteas Bioanalytics Inc. · Form D/A, Nov 10, 2021
SG
Spiros Garbis
President and director
DI
Dimitrios Iliopoulos
Director